wigraine suppositories suppository
organon canada ltd ltee - ergotamine tartrate; caffeine; belladonna - suppository - 1mg; 100mg; .1mg - ergotamine tartrate 1mg; caffeine 100mg; belladonna .1mg - sympatholytic (adrenergic blocking) agents
megral tabs tablet
glaxo wellcome inc. - ergotamine tartrate; cyclizine hydrochloride; caffeine - tablet - 2mg; 50mg; 100mg - ergotamine tartrate 2mg; cyclizine hydrochloride 50mg; caffeine 100mg - sympatholytic (adrenergic blocking) agents
migranal nasal spray 4mg/ml liquid
sterimax inc - dihydroergotamine mesylate - liquid - 0.5mg - dihydroergotamine mesylate 0.5mg - sympatholytic (adrenergic blocking) agents
kofetamin-tatpharm
tatchempharmpreparaty jsc - caffeine (caffeine anhydrous), ergotamine (ergotamine tartrate) - tablets coated - (91,5mg+1mg)
akynzeo
rafa laboratories ltd - netupitant; palonosetron as hydrochloride - capsules - netupitant 300 mg; palonosetron as hydrochloride 0.50 mg - palonosetron, combinations - prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of cancer chemotherapy, including, but not limited to, highly emetogenic chemotherapy.
stribild
gilead sciences israel ltd - cobicistate; elvitegravir; emtricitabine; tenofovir disoproxil as fumarate - film coated tablets - tenofovir disoproxil as fumarate 245 mg; emtricitabine 200 mg; cobicistate 150 mg; elvitegravir 150 mg - emtricitabine, tenofovir disoproxil, elvitegravir and cobicistat - stribild is indicated for the treatment of human immunodeficiency virus 1 (hiv 1) infection in adults aged 18 years and over who are antiretroviral treatment-naïve or are infected with hiv 1 without known mutations associated with resistance to any of the three antiretroviral agents in stribild.תוספת התוויה: 2/7/2019addition of new info to posology section: precaution in pregnant women
stribild
gilead sciences israel ltd - cobicistate; elvitegravir; emtricitabine; tenofovir disoproxil as fumarate - film coated tablets - tenofovir disoproxil as fumarate 245 mg; emtricitabine 200 mg; cobicistate 150 mg; elvitegravir 150 mg - emtricitabine, tenofovir disoproxil, elvitegravir and cobicistat - stribild is indicated for the treatment of human immunodeficiency virus 1 (hiv 1) infection in adults aged 18 years and over who are antiretroviral treatment-naïve or are infected with hiv 1 without known mutations associated with resistance to any of the three antiretroviral agents in stribild.
bellergamin tablets coated
sopharma jsc - phenobarbital, belladonna root liquid extract, ergotamine (ergotamine tartrate) - tablets coated - 0,1mg+ 0,3mg+ 20mg
kofetamin tatpharm tablets coated
"tatchempharmpreparaty" jsc - caffeine (caffeine anhydrous), ergotamine (ergotamine tartrate) - tablets coated - 91,5mg+ 1mg
trudhesa- dihydroergotamine mesylate spray, metered
impel pharmaceuticals inc. - dihydroergotamine mesylate (unii: 81axn7r2qt) (dihydroergotamine - unii:436o5hm03c) - trudhesa is indicated for the acute treatment of migraine with or without aura in adults. limitations of use trudhesa is not indicated for the preventive treatment of migraine. trudhesa is not indicated for the management of hemiplegic or basilar migraine. trudhesa is contraindicated in patients: - with concomitant use of strong cyp3a4 inhibitors, such as protease inhibitors (e.g., ritonavir, nelfinavir, or indinavir), macrolide antibiotics (e.g., erythromycin or clarithromycin), and antifungals (ketoconazole or itraconazole) [see warnings and precautions (5.1) and drug interactions (7.1)] - with ischemic heart disease (angina pectoris, history of myocardial infarction, or documented silent ischemia) or patients who have clinical symptoms or findings consistent with coronary artery vasospasm, including prinzmetal's variant angina [see warnings and precautions (5.4)] - with uncontrolled hypertension [see warnings and precautions (5.5)] - with peripheral arterial disease - with sepsis - following vascular surge